Text Size

Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT00535795
First received: September 24, 2007
Last updated: December 11, 2011
Last verified: December 2011
History of Changes
  Purpose

Phase III: Assess conventional RT w/ conventional Plus accelerated boost RT in the treatment of nasopharyngeal CA


Condition Intervention Phase
Nasopharyngeal CA
 Radiation: Radiation Therapy
 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by King Faisal Specialist Hospital & Research Center:

Primary Outcome Measures:
  • safety and efficacy [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: September 2007
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Conventional Radiation Therapy
 Radiation: Radiation Therapy
Radiation Therapy
Experimental: 2
Conventional Plus accelerated boost Radiation Therapy
 Radiation: Radiation Therapy
Radiation Therapy

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with nasopharyngeal CA
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00535795

Locations
Saudi Arabia
KFSH&RC
Riyadh, Saudi Arabia, 1211
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: Nasser Al Rajhi, MD KFSH&RC
  More Information

No publications provided

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT00535795     History of Changes
Other Study ID Numbers: RAC#0971-004
Study First Received: September 24, 2007
Last Updated: December 11, 2011
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 19, 2013